Literature DB >> 20977582

Timing of protein ingestion relative to resistance exercise training does not influence body composition, energy expenditure, glycaemic control or cardiometabolic risk factors in a hypocaloric, high protein diet in patients with type 2 diabetes.

T P Wycherley1, M Noakes, P M Clifton, X Cleanthous, J B Keogh, G D Brinkworth.   

Abstract

AIM: To investigate timing of protein ingestion relative to resistance exercise training (RT) on body composition, cardiometabolic risk factors, glycaemic control and resting energy expenditure (REE) during weight loss on a high-protein (HP) diet in overweight and obese patients with type 2 diabetes (T2DM).
METHODS: Thirty-four men/women with T2DM (age 57 ± 7 years and body mass index 34.9 ± 4.2 kg m(-2) ) were randomly assigned to the ingestion of a HP meal (860 kJ, 21 g protein, 0.7 g fat, 29.6 g carbohydrate) either immediately prior to RT or at least 2 h following RT. All participants followed a 16-week, energy-restricted (6-7 MJ day(-1) ), HP diet (carbohydrate : protein : fat 43 : 33 : 22) and participated in supervised RT (3 day week(-1) ). Outcomes were assessed pre- and postintervention at 16 weeks.
RESULTS: There was an overall reduction in bodyweight (-11.9 ± 6.1 kg), fat mass (-10.0 ± 4.4 kg), fat-free mass (-1.9 ± 3.1 kg), waist circumference (-12.1 ± 5.3 cm), REE (-742 ± 624 kJ day(-1) ), glucose (-1.9 ± 1.7 mmol l(-1) ), insulin (-6.1 ± 6.7 mU l(-1) ) and glycosylated haemoglobin (-1.1 ± 0.1%), p ≤ 0.01 time for all variables, with no difference between groups (p ≥ 0.41 group effect). Strength improved and cardiometabolic risk factors were reduced similarly in both groups; single repetition maximum chest press 11.0 ± 8.7 kg, single repetition maximum lat pull down 9.9 ± 6.0 kg, total cholesterol -0.6 ± 0.5 mmol l(-1) , high-density lipoprotein cholesterol -0.1 ± 0.2 mmol l(-1) , low-density lipoprotein cholesterol -0.3 ± 0.5 mmol l(-1) , triglycerides -0.6 ± 0.7 mmol l(-1) , blood pressure (systolic/diastolic) -13 ± 10/-7 ± 7 mmHg (p ≤ 0.04 time effect, p ≥ 0.24 group effect).
CONCLUSION: A HP, energy-restricted diet with RT was effective in improving glycaemic control, body composition, strength and cardiometabolic risk factors in overweight/obese patients with T2DM irrespective of altering the timing of protein ingestion relative to RT.
© 2010 CSIRO Food and Nutritional Sciences.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20977582     DOI: 10.1111/j.1463-1326.2010.01307.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  6 in total

1.  The effect of aerobic vs. resistance training on plasma homocysteine in individuals with type 2 diabetes.

Authors:  Alexandre de Souza E Silva; Fábio Vieira Lacerda; Maria Paula Gonçalves da Mota
Journal:  J Diabetes Metab Disord       Date:  2020-07-31

Review 2.  Evidence-based recommendations for natural bodybuilding contest preparation: nutrition and supplementation.

Authors:  Eric R Helms; Alan A Aragon; Peter J Fitschen
Journal:  J Int Soc Sports Nutr       Date:  2014-05-12       Impact factor: 5.150

3.  Weight loss on a structured hypocaloric diet with or without exercise improves emotional distress and quality of life in overweight and obese patients with type 2 diabetes.

Authors:  Thomas Philip Wycherley; Peter Marshall Clifton; Manny Noakes; Grant David Brinkworth
Journal:  J Diabetes Investig       Date:  2013-08-02       Impact factor: 4.232

4.  Evidence inconclusive - comment on article by Schoenfeld et al.

Authors:  David J Beale
Journal:  J Int Soc Sports Nutr       Date:  2016-10-10       Impact factor: 5.150

5.  Meal replacements for weight loss in type 2 diabetes in a community setting.

Authors:  Jennifer B Keogh; Peter M Clifton
Journal:  J Nutr Metab       Date:  2012-10-02

6.  The effect of protein timing on muscle strength and hypertrophy: a meta-analysis.

Authors:  Brad Jon Schoenfeld; Alan Albert Aragon; James W Krieger
Journal:  J Int Soc Sports Nutr       Date:  2013-12-03       Impact factor: 5.150

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.